Review
Aug 2026
Reprogramming the Breast Cancer Immune Microenvironment Using Nanoparticle-based Therapeutic Platforms
Future studies must aim to design nanoparticles that maximize tumor uptake, incorporate predictive biomarkers, and optimize clinical utility and therapeutic efficacy to enhance translational success.
A. Singh, Shatrudhan Prajapati, Shikha Yadav et al.
· Current Pharmacogenomics and... · 0 citations